Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Clinical trial NCT06613880 · RECRUITING
Trial details
- NCT number
- NCT06613880
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-24
- Primary completion
- 2026-01-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.